Intravenous Immunoglobulin Market Players, Demand, Production Growth, Top Key Players, Segmentation and Forecast to 2030
Intravenous Immunoglobulin Market
Intravenous
Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is
administered into the bloodstream to treat patients with inefficient or damaged
immune systems. IVIg provides the required antibodies by the human body to
fight out the immune deficiency, and the ensuing infectious attacks.
The global Intravenous
Immunoglobulin market has been evaluated as moderately
growing market and it is expected that the market will continue to grow
similarly in the near future. The demand for new products and therapy is
growing continuously. The intravenous immunoglobulin market size is expected to
grow by 7.50% and is expected to reach USD 20.96 Billion during the forecast
period
Immunodeficiency
disorder could be a hereditary issue (Primary disorders), or caused due to the
exposure to infections, mainly through bodily fluids, along with the cancer
drugs and chemotherapy, aging is one of the key risk factors too that could put
someone at higher risk of a damaged immune system.
People
nowadays are increasingly adopting heady & unhealthy lifestyles which
mirror the prevalence of damaged immune system. Factors such as immense stress,
lack of good quality sleep, inadequate & improper diet and sedentary
lifestyle are fuelling the prevalence of immunodeficiency disorder and
therefore, predominantly driving the growth of the market.
Major Key
Players:
Some of the Intravenous Immunoglobulin
Market Players are ABEONA THERAPEUTICS (US), Baxter
(US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc.
(China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma
(Switzerland), Shire (Republic of Ireland), AND others.
Segment Analysis
Intravenous Immunoglobulin (IVIg) Market has been
segmented on the basis of type which comprise Plaque psoriasis, Scalp
psoriasis, Nail psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular
psoriasis, Erythrodermic psoriasis and others. Plaque psoriasis is most common
type and about 80% of the cases are plaque psoriasis. On the basis of ivig
treatment type it segmented into Topical corticosteroids, Vitamin D analogues
(Calcipotriene, Calcitriol), Anthralin, Topical retinoids (Retinol, Tretinoin
(retinoic acid / retin-A /Steiva-A), Adapalene (Differin), Tazarotene),
Calcineurin inhibitors (tacrolimus (Prograf), pimecrolimus (Elidel)), Salicylic
acid, Coal tar, Moisturizers, and Others. Vitamin D analogs such as
Calcipotriene and Calcitriol very helpful and helps to slow skin cell growth.
Topical retinoids like are Retinol, Tretinoin (retinoic acid / retin-A
/Steiva-A), Adapalene (Differin), Tazarotene are vitamin A derivatives that
helps to reduce inflammation.
Regional Analysis
The North American region, heading with the presence of a large number
of key players and a well-established healthcare sector accounts for the
leading market in the global IVIg market.
The US market backed by the high expenditure on healthcare accounts for
the largest contributor to the growth of the regional market. Moreover, the
increasing prevalence of immunodeficiency disorder and rising demand for
treatment measures provide impetus to market growth.
The intravenous immunoglobulin market in the European region accounts
for the second-largest market, globally.
The IVIg market in Europe is fostered by the high per capita income and
robust healthcare penetration in the region. The strong market growth in
countries like Germany & France drives the regional market growth, large
scale. Moreover, factors such as the increasing investments in healthcare and
the rising number of patients with immune system diseases are helping the
market to create a larger revenue pocket.
The Asia Pacific intravenous immunoglobulin market is expected to
perceive an exponential growth. Factors such as the vast population and the
burgeoning medical treatment market, especially in India & China, drive the
growth of the regional market. Vietnam, Thailand, and Malaysia among the other
South East Asian countries are projected to contribute significantly to the
market growth in the region. With the growing Medical Tourism markets in India
& Malaysia, the APAC region will register a significant CAGR during the
review period.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment